Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms

ClinicalTrials.gov ID: NCT00874302

Public ClinicalTrials.gov record NCT00874302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Open Label, Randomized, Multicenter Study Evaluating the Safety and Efficacy of 25 mg and 50 mg Doses of Proellex to Assess Recurrence of Symptoms in the Treatment of Symptomatic Uterine Fibroids

Study identification

NCT ID
NCT00874302
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Repros Therapeutics Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Proellex Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 26, 2014

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Genesis Center for Clinical Research San Diego California 92103
Physician Care Clinical Research, LLC Sarasota Florida 34239
Atlanta Women's Research Inst. Atlanta Georgia 30342
Soapstone Center for Clinical Research Decatur Georgia 30034
York Clinical Consulting Marrero Louisiana 70072
Female Pelvic Medicine Grand Rapids Michigan 49503
Hawthorne Medical Research, Inc. Winston-Salem North Carolina 27103
Lyndhurst Gynecologic Associates Winston-Salem North Carolina 27103
Clinical Trials of America Eugene Oregon 97408
Thomas Jefferson University - Jefferson Center for Women's Medical Specialties Philadelphia Pennsylvania 19107-5127
Women's Care Center, PLC Research Memphis Associates Memphis Tennessee 38119
Meharry Medical College Nashville Tennessee 37208
Willowbend Health & Wellness Associates Plano Texas 75093

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00874302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00874302 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →